Clinical Trials Directory

Trials / Terminated

TerminatedNCT02016820

Effect of Acid Suppression Medication on Pediatric Microbiome

Effect of Proton Pump Inhibitors on the Colonic Microbiome in Children

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
0 Years – 4 Years
Healthy volunteers
Not accepted

Summary

The colonic microbiome is essential in health and disease, and is highly dynamic during the first several years of life. Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are widely used in children, but the effects of PPIs and H2RAs on the pediatric colonic microbiome are unknown. This study will determine whether acid suppression with these medications affects the microbiome of otherwise healthy children who are prescribed acid suppression for gastroesophageal reflux disease (GERD), and determine the duration and magnitude of microbiome changes.

Detailed description

Otherwise healthy children age 0-4 years old who are being considered for acid suppressive therapy for GERD will be eligible for this study. Subjects donate samples before and after being treated with PPIs or H2RAs (must donate at least 2 baseline pre-PPI samples to be eligible for final analysis). 30 total children who complete the study (anticipated 10 who receive lifestyle modification and 20 who receive PPIs or H2RAs). All children will donate 6 stools on or about weeks 0, 4, 12, 20, 38, and 64. The primary outcome will be a significant change in the overall diversity of the colonic microbiome after 8 weeks of PPIs or H2RAs (i.e., from week 12 to week 4), compared to after 4 weeks of lifestyle management.

Conditions

Interventions

TypeNameDescription
DRUGOmeprazole (suspension)1 mg/kg/day
OTHERLifestyle ModificationStandard lifestyle modification: small meals, upright feeding, elevation of the head of the bed

Timeline

Start date
2014-11-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2013-12-20
Last updated
2023-12-26
Results posted
2023-12-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02016820. Inclusion in this directory is not an endorsement.